Arthroscopic Treatment of Symptomatic Discoid Meniscus in Children: Long-term Follow-up

July 10, 2014

Institutional Review Board, Hospital for Special Surgery

The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.

For further information, see Understanding Clinical Trials/Research Studies.

Principal Investigator

Daniel W. Green, MD, MS, FAAP, FACS

Co-Investigators

Scott A. Rodeo, MD
David M. Dare, MD
Jonathan D. Haskel

Summary

Long-term follow-up of 28 patients after arthroscopic treatment of a discoid meniscus.

Inclusion/Exclusion Criteria

All patients in Dr. Green’s initial, short-term follow-up, study will be included.

Contact Information

David Dare
dared@hss.edu
703.200.8197